Changes in Intratumor Blood Flow After Carbon-Ion Radiation Therapy for Early-Stage Breast Cancer.

Purpose: This study aimed to quantify the changes in intratumoral blood flow after carbon-ion radiation therapy (CIRT) for early-stage breast cancer and analyze their clinical significance. Patients and Methods: We included 38 patients with early-stage breast cancer who underwent CIRT. Dynamic imaging was performed using a 3T superconducting magnetic resonance scanner to quantify the washin index (idx), which reflects contrast uptake, and washout idx, which reflects the rate of contrast washout from tumor tissue. The changes in the apparent diffusion coefficient, washin idx, and washout idx were examined before CIRT and at 1 and 3 months after treatment. Clinical factors and imaging features were examined using univariate and receiver operating characteristic curve analyses to identify factors predicting clinical complete response (cCR). Results: The median observation period after CIRT was 51 (range: 12-122) months. During the observation period, 31 of the 38 patients achieved cCR, and 22 achieved cCR within 12 months. Tumor size (P < .001), washin idx (P = .043), and washout idx (P < .001) decreased significantly 1-month after CIRT. In contrast, the apparent diffusion coefficient values (P < .001) increased significantly 1-month after CIRT. Univariate analysis suggested that the washin idx after 1 and 3 months of CIRT was associated with cCR by 12 months post-CIRT (P = .028 and .021, respectively). No other parameters were associated with cCR by 12 months post-CIRT. Furthermore, receiver operating characteristic curve analyses showed that the area under the curve values of washin idx after 1 and 3 months of CIRT was 0.78 (specificity 75%, sensitivity 80%) and 0.73 (specificity 75%, sensitivity 71%), respectively. Conclusion: Tumor changes can be quantified early after CIRT using contrast-enhanced magnetic resonance imaging in patients with breast cancer. Washin idx values 1 and 3 months after CIRT were associated with cCR within 12 months post-CIRT.

Homo naledi cranial remains from the Lesedi chamber of the rising star cave system, South Africa.

Excavations in the Lesedi Chamber (U.W. 102) of the Rising Star cave system from 2013 to 2015 resulted in the recovery of 131 fossils representing at least three individuals attributed to Homo naledi. Hominin fossils were recovered from three collection areas within the Lesedi Chamber. A partial skull with near complete dentition (LES1) and an associated partial skeleton were recovered from Area 102a, while craniodental remains from two other individuals were recovered from Areas 102b and 102c. Here we present detailed anatomical descriptions and metrical comparisons of the Lesedi Chamber H. naledi craniodental remains that preserve diagnostic morphology. The LES1 skull is a presumed male that is slightly larger in size, and shows greater development of ectocranial structures compared to other H. naledi specimens from the Dinaledi Chamber of the Rising Star cave system. Otherwise the Lesedi fossils are notably similar to the Dinaledi fossils in shape and morphology. The Lesedi fossils also preserve the delicate nasal and lacrimal bones that are otherwise unrecorded in the Dinaledi sample. Limited morphological differences between the Dinaledi and Lesedi Chamber hominin samples provides support for the hypothesis that these two assemblages share a close phyletic relationship.

Considerations for comparative tobacco product assessments based on smoke constituent yields.

Cigarette smoke is a complex mixture of more than 8000 smoke constituents. The quantification of selected mainstream smoke constituent yields is one of the methods to evaluating and comparing the performance of different products. Numerous regulatory and scientific advisory bodies have used cigarette smoke constituent yield data for reporting and product comparison purposes. For more than a decade limitations of the indiscriminate application of traditional statistical methods such as the t-test for differences in comparative smoke constituent yield assessments lacking a specific study design, have been highlighted. In the present study, the variability of smoke constituent yields is demonstrated with data obtained under the ISO smoking regime for the Kentucky reference cigarette 3R4F and one commercial brand, analyzed on several occasions between 2007 and 2014. Specifically it is shown that statistically significant differences in the yields of selected smoke constituents do not readily translate to differences between products, and that tolerances need to be defined. To this end, two approaches have been proposed in the literature--minimal detectable differences, and the statistical equivalence. It is illustrated how both approaches provide more meaningful comparison outcomes than the statistical t-test for differences. The present study provides considerations relevant for comparative tobacco product assessments both in the scientific and regulatory contexts.